Quick Takeaways
- Affinity Asset Advisors, LLC filed SCHEDULE 13G/A for Forte Biosciences, Inc. Common Stock, par value $0.001 per share (FBRX).
- Disclosed ownership: 7.3%.
- Date of event: 31 Mar 2026.
Affinity Asset Advisors, LLC - 31 Mar 2026 SCHEDULE 13G/A Report for Forte Biosciences, Inc. Common Stock, par value $0.001 per share (FBRX)
- Filing Manager
- Affinity Asset Advisors, LLC
- Reporting Manager
- Affinity Asset Advisors, LLC
- Symbol
- FBRX
- Shares outstanding
- 13,861,507 shares
- Disclosed Ownership
- 1,011,890 shares
- Ownership
- 7.3%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 May 2026, 16:15:57 UTC
- Date of event
- 31 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Affinity Asset Advisors, LLC disclosed 7.3% ownership in Forte Biosciences, Inc. Common Stock, par value $0.001 per share (FBRX) on 31 Mar 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 May 2026, 16:15.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Affinity Asset Advisors, LLC | 7.3% | 1,011,890 | 1,011,890 | 0 | /s/ Andrew Weinstein | Andrew Weinstein, Chief Financial Officer and Chief Compliance Officer | |
| Michael Cho | 7.3% | 1,011,890 | 1,011,890 | 0 | /s/ Michael Cho | Michael Cho, Self |